AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases
In December, The Conversation hosted a webinar on AI’s revolutionary position in drug discovery and improvement. Science and expertise editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in computational techniques…